The NF-κB binding site is reportedly important for EGR1-mediated IL-8 upregulation, and EGR1 knockdown inhibits IL-8 production and IL-8-mediated prostate cancer cell invasion. This evidence concerns the gene NFKB1 and prostate cancer.